Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology
25/08/2025 17:55
|
Medical, Health & Aged Care
* Total equity and debt raising of ~$90 million provides runway to 2H 2027
* Strong support from existing and new investors including SPRIM Global Investments
* Funds will be used to scale-up...